Please login to the form below
constipation
This page shows the latest constipation news and features for those working in and with pharma, biotech and healthcare.
Mallinckrodt pays $1.2bn for Sucampo Pharma
As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic
Latest news
-
NICE backs Allergan's IBS therapy Truberzi
includes Linzess (linaclotide) for IBS with constipation.
-
FDA fast-tracks Pfizer and Lilly's tanezumab
unpleasant side effects such as severe constipation.
-
FDA approves Synergy's constipation drug Trulance
Synergy Pharma is celebrating after the FDA approved Trulance, its drug for the treatment of chronic idiopathic constipation (CIC) in adults. ... There are around 42 million people in the US who suffer from constipation, according to the National
-
Valeant's proposed sale of Salix to Takeda 'in jeopardy'
That push will also extend to opioid-induced constipation drug Relistor (methylnaltrexone bromide), and comments made by the company in its announcement lend some credence to the rumours of the breakdown
-
McCann Health and Langland lead Global Awards 2016 winners
The work saw the agency create a music video for Typharm's Docusol brand, a constipation relief for children, along with a website offering tips and guidance for parents.
More from news
Approximately 9 fully matching, plus 75 partially matching documents found.
Latest Intelligence
-
Erectile dysfunction, constipation, vaginal dryness and other laughing matters
Erectile dysfunction, constipation, vaginal dryness and other laughing matters. Humour in healthcare brand communications: when and where is it appropriate? ... Diarrhoea, constipation, flatulence, leaky bladder, vaginal dryness - it’s all fertile
-
Taking a lean and careful approach
His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation.
-
Deal Watch March 2016
$110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.
-
Oral biologics delivery still elusive
years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.
-
Medius Deal Watch table for March 2015
941. AstraZeneca / Daiichi Sankyo. Co-commercialisation US . Marketed Movantik (naloxegol) for opioid induced constipation.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Ironwood appoints Edward Owens to board
irritable bowel syndrome and constipation. “
-
Norgine’s Karen Hockey promoted to head of global marketing
Norgine’ s Karen Hockey promoted to head of global marketing. Appointment follows nearly two years as global brand manager for constipation treatment Movicol. ... Hockey's promotion comes after nearly two years as global brand manager for constipation
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
FCB Halesway
Stroke prevention in atrial fibrillation. Galen. Branded generics. Constipation. Vitamin D supplements.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Senior Programme Executive
-
Salary TBC
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
-
Scientific Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
-
Senior Medical Writer
-
Great salary and bebefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Rainmaker Healthcare Communications
Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
